Related references
Note: Only part of the references are listed.Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
Rachael F. Grace et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload
Andrew J. Schwartz et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Phase 1 Single- and Multiple-Ascending-Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers
Hua Yang et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia
Alessandro Matte et al.
JCI INSIGHT (2019)
Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis
Alessandro Matte et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Diverse roles of mitochondria in ischemic stroke
Jenq-Lin Yang et al.
REDOX BIOLOGY (2018)
An Orchestrated Balance between Mitochondria Biogenesis, Iron-Sulfur Cluster Synthesis and Cellular Iron Acquisition
Ping La et al.
BLOOD (2018)
Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia
Thomas R. L. Klei et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Regulation of mitochondrial biogenesis in erythropoiesis by mTORC1-mediated protein translation
Xin Liu et al.
NATURE CELL BIOLOGY (2017)
AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency
Charles Kung et al.
BLOOD (2017)
Erythroferrone and matriptase-2 independently regulate hepcidin expression
Sharraya Aschemeyer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases
Ryan M. Whitaker et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice
Antonella Nai et al.
BLOOD (2016)
Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera
Carla Casu et al.
BLOOD (2016)
Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases
Robert B. Cameron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice
Sirinart Kumfu et al.
LIFE SCIENCES (2016)
PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation
Ninel Azoitei et al.
MOLECULAR CANCER (2016)
PKM2 and cancer: The function of PKM2 beyond glycolysis
Gaochao Dong et al.
ONCOLOGY LETTERS (2016)
NCOA4 Deficiency Impairs Systemic Iron Homeostasis
Roberto Bellelli et al.
CELL REPORTS (2016)
Mitochondrial Changes in β°-Thalassemia/Hb E Disease
Kornpat Khungwanmaythawee et al.
PLOS ONE (2016)
The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis
Alessandro Matte et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease
Luca Dalle Carbonare et al.
BLOOD (2015)
Cytokinesis failure in RhoA-deficient mouse erythroblasts involves actomyosin and midbody dysregulation and triggers p53 activation
Diamantis G. Konstantinidis et al.
BLOOD (2015)
Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages
Eva M. Palsson-McDermott et al.
CELL METABOLISM (2015)
β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies
Stefano Rivella
HAEMATOLOGICA (2015)
Pyruvate kinase M2 at a glance
Weiwei Yang et al.
JOURNAL OF CELL SCIENCE (2015)
Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression
Q. Xu et al.
ONCOGENE (2015)
β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies
Stefano Rivella
HAEMATOLOGICA (2015)
FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis
Xin Zhang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Cell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis
Ying-Hua Wang et al.
CELL (2014)
Transcriptional regulation by hypoxia inducible factors
Veronica L. Dengler et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence
Alessandro Matte et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice
Sara Santos Franco et al.
HAEMATOLOGICA (2014)
An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
Michael Dussiot et al.
NATURE MEDICINE (2014)
Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis
Jing Liu et al.
BLOOD (2013)
Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2
Mohd Askandar Iqbal et al.
MOLECULAR CANCER (2013)
Analysis of GSH and GSSG after derivatization with N-ethylmaleimide
Daniela Giustarini et al.
NATURE PROTOCOLS (2013)
Oxidative Stress and β-Thalassemic Erythroid Cells behind the Molecular Defect
Lucia De Franceschi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia
Erik R. Anderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Loss of Yme1L perturbates mitochondrial dynamics
Y. Ruan et al.
CELL DEATH & DISEASE (2013)
Distortion of β-globin Chain of Hemoglobin Alters the Pathway of Erythrocytic Glucose Metabolism Through Band 3 Protein
Indrani Chakraborty et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
YME1L controls the accumulation of respiratory chain subunits and is required for apoptotic resistance, cristae morphogenesis, and cell proliferation
Lukas Stiburek et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic erythropoiesis
Lucia De Franceschi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
Dimitrios Anastasiou et al.
SCIENCE (2011)
Peroxiredoxin-2 expression is increased in β-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress
Alessandro Matte et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Hypoxia Regulates the Ferrous Iron Uptake and Reactive Oxygen Species Level via Divalent Metal Transporter 1 (DMT1) Exon1B by Hypoxia-Inducible Factor-1
Dan Wang et al.
IUBMB LIFE (2010)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
K-CL co-transport plays an important role in normal and β thalassemic erythropoiesis
Lucia De Franceschi et al.
HAEMATOLOGICA (2007)
Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin
Sara Gardenghi et al.
BLOOD (2007)
Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples
IH Shaik et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2006)
Nitric oxide transcriptionally down-regulates specific isoforms of divalent metal transporter (DMT1) via NF-κB
PN Paradkar et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity
S Aizawa et al.
EXPERIMENTAL HEMATOLOGY (2005)
Medical progress:: β-thalassemia
D Rund et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Ineffective erythropoiesis in the spleen of a patient with pyruvate kinase deficiency
S Aizawa et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Share Paper
